MX2012006897A - Heterocyclic compounds as janus kinase inhibitors. - Google Patents

Heterocyclic compounds as janus kinase inhibitors.

Info

Publication number
MX2012006897A
MX2012006897A MX2012006897A MX2012006897A MX2012006897A MX 2012006897 A MX2012006897 A MX 2012006897A MX 2012006897 A MX2012006897 A MX 2012006897A MX 2012006897 A MX2012006897 A MX 2012006897A MX 2012006897 A MX2012006897 A MX 2012006897A
Authority
MX
Mexico
Prior art keywords
formula
kinase inhibitors
heterocyclic compounds
janus kinase
compounds
Prior art date
Application number
MX2012006897A
Other languages
Spanish (es)
Inventor
Pravin L Kotian
Yarlagadda S Babu
Original Assignee
Biocryst Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocryst Pharm Inc filed Critical Biocryst Pharm Inc
Priority claimed from PCT/US2010/061912 external-priority patent/WO2011079230A2/en
Publication of MX2012006897A publication Critical patent/MX2012006897A/en

Links

Abstract

The invention provides compounds of formula (I): (Formula (I)), or a salt thereof as described herein. The invention also provides pharmaceutical compositions comprising a compound of formula (I), processes for preparing compounds of formula (I), intermediates useful for preparing compounds of formula (I) and therapeutic methods for suppressing an immune response or treating cancer or a hematologic malignancy using compounds of formula (I).
MX2012006897A 2009-12-23 2010-12-22 Heterocyclic compounds as janus kinase inhibitors. MX2012006897A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28997509P 2009-12-23 2009-12-23
PCT/US2010/061912 WO2011079230A2 (en) 2009-12-23 2010-12-22 Heterocyclic compounds as janus kinase inhibitors
US201061289978P 2010-12-23 2010-12-23

Publications (1)

Publication Number Publication Date
MX2012006897A true MX2012006897A (en) 2012-07-04

Family

ID=46940855

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012006897A MX2012006897A (en) 2009-12-23 2010-12-22 Heterocyclic compounds as janus kinase inhibitors.

Country Status (1)

Country Link
MX (1) MX2012006897A (en)

Similar Documents

Publication Publication Date Title
WO2011031554A3 (en) Heterocyclic compounds as janus kinase inhibitors
MX2012001420A (en) Pyrrolo [1, 2-b] pyridazine derivatives as janus kinase inhibitors.
WO2011079230A3 (en) Heterocyclic compounds as janus kinase inhibitors
MX352672B (en) Heterocyclic compounds as mdm2 inhibitors for the treatment of cancer.
TN2012000559A1 (en) Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer
EA201170872A1 (en) PROTEINKINASE INHIBITORS
MX2011012037A (en) Heteroaryl compounds as pikk inhibitors.
PH12015501585A1 (en) Manufacturing process for pyrimidine derivatives
MX2011009796A (en) Inhibitors of pi3 kinase.
MX2012000709A (en) Pyrrolopyridine inhibitors of kinases.
HK1131608A1 (en) Pyridinone compounds
WO2009155121A3 (en) Inhibitors of pi3 kinase
MX362550B (en) Heterocyclic inhibitors of glutaminase.
MY149512A (en) Pyrazolylaminopyridine derivatives useful as kinase inhibitors
MX2015012427A (en) Heteroaryl acid morpholinone compounds as mdm2 inhibitors for the treatment of cancer.
MX2013012776A (en) Amino-pyridine-containing spleen tyrosine kinase (syk) inhibitors.
BR112012029994A2 (en) heterocyclic compounds as janus kinase inhibitors
MX2011011335A (en) Inhibitors of pi3 kinase and / or mtor.
JO3007B1 (en) Compounds and compositions as protein kinase inhibitors
MX2021006544A (en) Cdk9 inhibitors and polymorphs thereof for use as agents for treatment of cancer.
MX2011011776A (en) Triptolide prodrugs.
EA201170617A1 (en) PYRAZOLYLAMINOPIRIDINE AS FAK INHIBITORS
MX2012015100A (en) Heteroaryl compounds and compositions as protein kinase inhibitors.
UA100545C2 (en) Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
NZ700356A (en) Pyrazole compounds as sglt1 inhibitors

Legal Events

Date Code Title Description
FA Abandonment or withdrawal